- Report
- September 2023
- 190 Pages
Global
From €2393EUR$2,490USD£2,052GBP
- Report
- February 2024
- 180 Pages
Global
From €4710EUR$4,900USD£4,039GBP
- Report
- February 2024
- 181 Pages
Global
From €4710EUR$4,900USD£4,039GBP
- Report
- November 2023
- 190 Pages
Global
From €4710EUR$4,900USD£4,039GBP
- Report
- November 2023
- 182 Pages
Global
From €4710EUR$4,900USD£4,039GBP
- Report
- October 2023
- 180 Pages
Global
From €4710EUR$4,900USD£4,039GBP
- Report
- October 2023
- 178 Pages
Global
From €4710EUR$4,900USD£4,039GBP
- Report
- November 2023
- 178 Pages
Global
From €4710EUR$4,900USD£4,039GBP
- Report
- April 2024
- 185 Pages
Global
From €4710EUR$4,900USD£4,039GBP
- Clinical Trials
- April 2024
- 180 Pages
Global
From €2403EUR$2,500USD£2,061GBP
- Clinical Trials
- April 2024
- 230 Pages
Global
From €2883EUR$3,000USD£2,473GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1922EUR$2,000USD£1,648GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1922EUR$2,000USD£1,648GBP
- Drug Pipelines
- April 2024
- 250 Pages
Global
From €2403EUR$2,500USD£2,061GBP
- Drug Pipelines
- April 2024
- 40 Pages
Global
From €1201EUR$1,250USD£1,030GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1201EUR$1,250USD£1,030GBP
- Drug Pipelines
- February 2024
- 180 Pages
Global
From €2883EUR$3,000USD£2,473GBP
- Report
- July 2023
- 181 Pages
Global
From €2403EUR$2,500USD£2,061GBP
- Drug Pipelines
- April 2024
- 210 Pages
Global
From €2403EUR$2,500USD£2,061GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1201EUR$1,250USD£1,030GBP
The Breast Cancer market is a subset of the Women's Health market, focusing on the diagnosis, treatment, and prevention of breast cancer. It includes a range of products and services, from medical devices and pharmaceuticals to patient education and support. Breast cancer is the most common cancer among women worldwide, and the market is driven by the need to improve early detection and treatment outcomes.
The Breast Cancer market is highly competitive, with a range of players from large multinationals to small start-ups. Companies in the market include Roche, Novartis, AstraZeneca, Pfizer, Merck, and Johnson & Johnson, as well as smaller players such as Myriad Genetics, Genomic Health, and Natera. Show Less Read more